Biointron introduces RushData platform for AI-driven antibody discovery
RushData incorporates antibody expression, binding analysis, and early developability profiling within one standardised workflow.
Drug Development
Kenvue’s Tylenol with Naproxen gains FDA approval
BeOne to invest $300m in US manufacturing facility expansion
FDA grants fast track designation for Lundbeck’s Lu AH69593
Affinia Therapeutics receives FDA orphan drug designation for AFTX-201
Evogene and ELEO to develop new oral PCSK9 inhibitors
Kyowa Kirin EMEA’s Crysvita approved by EC for infants with XLH
Cellares and Papillon partner for PPL-001 manufacturing automation
